These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6809453)

  • 1. Hormonal contributions to the recruitment of follicular development following ovarian wedge resection in polycystic ovary syndrome.
    Araki S; Chikazawa K; Akabori A; Ijima K; Tamada T
    Endocrinol Jpn; 1982 Feb; 29(1):57-68. PubMed ID: 6809453
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal and clinical effects of multifollicular puncture and resection on the ovaries of polycystic ovary syndrome.
    Utsunomiya T; Sumioki H; Taniguchi I
    Horm Res; 1990; 33 Suppl 2():35-9. PubMed ID: 2151330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of celioscopic ovarian resection in patients with polycystic ovaries.
    Campo S; Garcea N; Caruso A; Siccardi P
    Gynecol Obstet Invest; 1983; 15(4):213-22. PubMed ID: 6220946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ovarian wedge resection and incision on circulating gonadotropin in patients with polycystic ovarian disease.
    Tanaka T; Fujimoto S; Kutsuzawa T
    Int J Fertil; 1978; 23(2):93-9. PubMed ID: 30730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone levels following wedge resection in polycystic ovary syndrome.
    Mahesh VB; Toledo SP; Mattar E
    Obstet Gynecol; 1978 Jan; 51(1 Suppl):64s-69s. PubMed ID: 144874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.
    Szilágyi A; Rossmanith W; Csermely T; Csaba I
    Arch Gynecol Obstet; 1990; 248(1):31-5. PubMed ID: 2124095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome.
    Greenblatt E; Casper RF
    Am J Obstet Gynecol; 1987 Feb; 156(2):279-85. PubMed ID: 2950757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
    Wu X; Sallinen K; Zhou S; Su Y; Pöllänen P; Erkkola R
    Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease.
    Aakvaag A; Gjønnaess H
    Br J Obstet Gynaecol; 1985 Dec; 92(12):1258-64. PubMed ID: 3936533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of laparoscopic multiple punch resection of the ovary on hypothalamo-pituitary axis in polycystic ovary syndrome.
    Sumioki H; Utsunomyiya T; Matsuoka K; Korenaga M; Kadota T
    Fertil Steril; 1988 Oct; 50(4):567-72. PubMed ID: 2971578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
    Polson DW; Kiddy DS; Mason HD; Franks S
    Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of the renin-angiotensin-aldosterone system to plasma gonadotropin, prolactin, and ovarian steroid patterns during the menstrual cycle.
    Kaulhausen H; Leyendecker G; Benker G; Breuer H
    Arch Gynakol; 1978 Jul; 225(3):179-200. PubMed ID: 354555
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine effects of danazol in menstruating women.
    Guillebaud J; Fraser IS; Thorburn GD; Jenken G
    J Int Med Res; 1977; 5 Suppl 3():57-66. PubMed ID: 913882
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Pituitary-ovarian relationships in polycystic ovarian disease.
    Baird DT; Corker CS; Fraser WM; Michie EA; Van Look PF
    J Endocrinol; 1975 Mar; 64(3):53P-54P. PubMed ID: 1133543
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.